Celldex Therapeutics Q4 EPS $(1.22) Misses $(1.00) Estimate, Sales $100.000K Miss $1.477M Estimate

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.00) by 21.88 percent. This is a 71.83 percent decrease over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $100.000 thousand which missed the analyst consensus estimate of $1.477 million by 93.23 percent. This is a 91.49 percent decrease over sales of $1.175 million the same period last year.